News - Innovative Cellular Therapeutics

ICT Receives FDA Clearance of IND Application to Initiate a Phase 1 Clinical Trial for GCC19CART https://www.ictbio.com/wp-content/uploads/2019/12/christian-wiediger-nSE1dxjNhyY-unsplash.jpg 1366 911 Innovative Cellular Therapeutics Innovative Cellular Therapeutics https://www.ictbio.com/wp-content/uploads/2019/12/christian-wiediger-nSE1dxjNhyY-unsplash.jpg 1 9 月, 2021 13 1 月, 2022

1 9 月, 2021

ICT Receives FDA Clearance of IND Application to Initiate a Phase 1 Clinical Trial for GCC19CART

ROCKVILLE, Md., Sept. 01, 2021 (GLOBE NEWSWIRE) — Innovative Cellular Therapeutics (ICT), a Maryland based clinical stage biotechnology company developing the CoupledCAR® platform of chimeric antigen receptor (CAR) T-cell therapies..

Innovative Cellular Therapeutics to Participate in Upcoming Investor Conferences https://www.ictbio.com/wp-content/uploads/2020/11/trinity-nguyen-22l_gC9lfRE-unsplash-1-scaled-e1605020238752.jpg 1704 1858 Innovative Cellular Therapeutics Innovative Cellular Therapeutics https://www.ictbio.com/wp-content/uploads/2020/11/trinity-nguyen-22l_gC9lfRE-unsplash-1-scaled-e1605020238752.jpg 10 11 月, 2020 20 1 月, 2022

10 11 月, 2020

Innovative Cellular Therapeutics to Participate in Upcoming Investor Conferences

ROCKVILLE, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) — …

Innovative Cellular Therapeutics to Present CoupledCAR® Solid Tumor CAR-T Clinical Data at Upcoming Scientific Meetings https://www.ictbio.com/wp-content/uploads/2020/11/cdc-wDxFn_dBEC0-unsplash-1.jpg 671 768 Innovative Cellular Therapeutics Innovative Cellular Therapeutics https://www.ictbio.com/wp-content/uploads/2020/11/cdc-wDxFn_dBEC0-unsplash-1.jpg 10 11 月, 2020 7 6 月, 2021

10 11 月, 2020

Innovative Cellular Therapeutics to Present CoupledCAR® Solid Tumor CAR-T Clinical Data at Upcoming Scientific Meetings

ROCKVILLE, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) — …

Innovative Cellular Therapeutics to Present New Clinical Data with CoupledCAR® CAR-T in Colon Cancer at the LifeSci Partners Private Company Virtual Summer Symposium on August 5, 2020 https://www.ictbio.com/wp-content/uploads/2020/07/ictLifeSci-Partners-Private-Company-Virtual-Summer-Symposium-copy-1-1.jpg 470 631 Innovative Cellular Therapeutics Innovative Cellular Therapeutics https://www.ictbio.com/wp-content/uploads/2020/07/ictLifeSci-Partners-Private-Company-Virtual-Summer-Symposium-copy-1-1.jpg 29 7 月, 2020 7 6 月, 2021

29 7 月, 2020

Innovative Cellular Therapeutics to Present New Clinical Data with CoupledCAR® CAR-T in Colon Cancer at the LifeSci Partners Private Company Virtual Summer Symposium on August 5, 2020

ROCKVILLE, Md., July 28, 2020 (GLOBE NEWSWIRE) — …

Innovative Cellular Therapeutics Announces Details of Two Abstracts on its Novel CoupledCAR® Solid Tumor CAR-T Technology to be Presented Orally at the 23rd American Society of Gene & Cell Therapy Meeting https://www.ictbio.com/wp-content/uploads/2020/04/Ictbio-e1588171868301.jpeg 1719 1732 Innovative Cellular Therapeutics Innovative Cellular Therapeutics https://www.ictbio.com/wp-content/uploads/2020/04/Ictbio-e1588171868301.jpeg 29 4 月, 2020 7 6 月, 2021

29 4 月, 2020

Innovative Cellular Therapeutics Announces Details of Two Abstracts on its Novel CoupledCAR® Solid Tumor CAR-T Technology to be Presented Orally at the 23rd American Society of Gene & Cell Therapy Meeting

ROCKVILLE, Md., April 29, 2020 (GLOBE NEWSWIRE) —…

Innovative Cellular Therapeutics Announces Acceptance of Abstract on its Novel CoupledCAR® Technology for Treating Colorectal Cancer for Oral Presentation at the 23rd American Society of Gene & Cell Therapy (ASGCT) Annual Meeting https://www.ictbio.com/wp-content/uploads/2020/04/photo-1561634109-465ffe688b50.jpeg 1300 1625 Innovative Cellular Therapeutics Innovative Cellular Therapeutics https://www.ictbio.com/wp-content/uploads/2020/04/photo-1561634109-465ffe688b50.jpeg 14 4 月, 2020 7 6 月, 2021

14 4 月, 2020

Innovative Cellular Therapeutics Announces Acceptance of Abstract on its Novel CoupledCAR® Technology for Treating Colorectal Cancer for Oral Presentation at the 23rd American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

ROCKVILLE, Md., April 14, 2020 — Innovative Cellu…

Maryland Tech Council Announces Nomination of Innovative Cellular Therapeutics as “Emerging Life Sciences Company of the Year” Finalist https://www.ictbio.com/wp-content/uploads/2020/03/icti-Maryland-e1583847435442.jpg 1745 1664 Innovative Cellular Therapeutics Innovative Cellular Therapeutics https://www.ictbio.com/wp-content/uploads/2020/03/icti-Maryland-e1583847435442.jpg 10 3 月, 2020 7 6 月, 2021

10 3 月, 2020

Maryland Tech Council Announces Nomination of Innovative Cellular Therapeutics as “Emerging Life Sciences Company of the Year” Finalist

ROCKVILLE, Md., March 10, 2020 (GLOBE NEWSWIRE) —…

Innovative Cellular Therapeutics Announces FDA Clearance of IND for its Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy https://www.ictbio.com/wp-content/uploads/2019/06/ict-image.jpg 3000 2250 Innovative Cellular Therapeutics Innovative Cellular Therapeutics https://www.ictbio.com/wp-content/uploads/2019/06/ict-image.jpg 4 12 月, 2019 4 12 月, 2019

4 12 月, 2019

Innovative Cellular Therapeutics Announces FDA Clearance of IND for its Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy

ROCKVILLE, Md., December 4, 2019 — Innovative Cel…

Innovative Cellular Therapeutics Announces Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting https://www.ictbio.com/wp-content/uploads/2019/06/hisu-lee-81398-unsplash.jpg 805 612 Innovative Cellular Therapeutics Innovative Cellular Therapeutics https://www.ictbio.com/wp-content/uploads/2019/06/hisu-lee-81398-unsplash.jpg 8 5 月, 2019 5 12 月, 2019

8 5 月, 2019

Innovative Cellular Therapeutics Announces Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

ICT’s lead “armored” CAR-T program, ICTCAR014, demonstr…

Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA https://www.ictbio.com/wp-content/uploads/2019/03/dylan-gillis-533818-unsplash.jpg 1366 911 Innovative Cellular Therapeutics Innovative Cellular Therapeutics https://www.ictbio.com/wp-content/uploads/2019/03/dylan-gillis-533818-unsplash.jpg 19 3 月, 2019 3 12 月, 2019

19 3 月, 2019

Innovative Cellular Therapeutics Announces Successful Completion of Pre-IND Meeting With FDA

ROCKVILLE, Md., March 19, 2019 (GLOBE NEWSWIRE) —…